Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 62.

Weber, S C; Beck-Schimmer, B; Kajdi, M-E; Müller, D; Tobler, Philippe N; Quednow, B B (2016). Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans. Translational Psychiatry, 6(7):e850.

Vonmoos, M; Schütz, C G; Quednow, B B (2016). Kognitive und sozial-kognitive Folgen des Kokainkonsums. Suchtmedizin - Addiction Medicine, 14(4):207-212.

Kroll, S L; Herdener, M; Quednow, B B (2016). Nicht-medizinischer Gebrauch von Opiatanalgetika: Verbreitung, kognitive Folgen und Behandlung. Nervenheilkunde, 35(11):779-783.

Wittwer, Amrei; Hulka, Lea M; Heinimann, Hans R; Vonmoos, Matthias; Quednow, B B (2016). Risky decisions in a lottery task are associated with an increase of cocaine use. Frontiers in Psychology, 7:640.

Kirsch, P; Kübler, A; Feld, G B; Quednow, B B (2016). Widersteht der Abgrenzung – Für eine Einheit in der Vielfalt. Psychologische Rundschau, 67:193-196.

Gachet, M S; Rhyn, P; Bosch, O G; Quednow, B B; Gertsch, J (2015). A quantitiative LC-MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 976-977:6-18.

Schleim, S; Quednow, B B (2015). Cognitive Enhancement: Ein kritischer Rückblick auf fünfzehn Jahre Forschung. INFO Neurologie & Psychiatrie, 13:2-5.

Schmid, Y; Hysek, Cédric M; Preller, Katrin H; Bosch, Oliver G; Bilderbeck, A C; Rogers, R D; Quednow, B B; Liechti, Matthias E (2015). Effects of methylphenidate and MDMA on appraisal of pictures of erotic stimuli and intimate relationships. European Neuropsychopharmacology, 25:17-25.

Bosch, O G; Eisenegger, Christoph; Gertsch, Jürg; von Rotz, R; Dornbierer, D; Gachet, M S; Heinrichs, M; Wetter, T C; Seifritz, Erich; Quednow, B B (2015). Gamma-hydroxybutyrate enhances mood and prosocial behavior without affecting plasma oxytocin and testosterone. Psychoneuroendocrinology, 62:1-10.

Havranek, M M; Vonmoos, Matthias; Müller, C P; Büetiger, J R; Tasiudi, Eve; Hulka, Lea M; Preller, Katrin H; Mössner, R; Grünblatt, Edna; Seifritz, Erich; Quednow, B B (2015). Serotonin transporter and tryptophan hydroxylase gene variations mediate working memory deficits of cocaine users. Neuropsychopharmacology, 40:2929-2937.

Hysek, C M; Schmid, Y; Simmler, L D; Domes, G; Heinrichs, M; Eisenegger, C; Preller, K H; Quednow, B B; Liechti, M E (2014). MDMA enhances emotional empathy and prosocial behavior. Social Cognitive and Affective Neuroscience, 9(11):1645-1652.

Quednow, B B (2014). Titus Lerners Kunst im Spiegel unseres Gehirns. In: Lerner, Titus. Titus Lerner. Eine Werkauswahl 2009-2014. Witten: ars momentum, 58-59.

Quednow, B B; Brzózka, M M; Rossner, M J (2014). Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective. Cellular and Molecular Life Sciences, 71(15):2815-2835.

Hulka, L M; Eisenegger, C; Preller, K H; Vonmoos, M; Jenni, D; Bendrick, K; Baumgartner, M R; Seifritz, E; Quednow, B B (2014). Altered social and non-social decision-making in recreational and dependent cocaine users. Psychological Medicine, 44(05):1015-1028.

Preller, Katrin H; Hulka, Lea M; Vonmoos, M; Jenni, D; Baumgartner, M R; Seifritz, E; Dziobek, I; Quednow, B B (2014). Impaired emotional empathy and related social network deficits in cocaine users. Addiction Biology, 19(3):452-466.

Madry, Milena M; Steuer, Andrea E; Vonmoos, Matthias; Quednow, B B; Baumgartner, Markus R; Kraemer, Thomas (2014). Retrospective monitoring of long-term recreational and dependent cocaine use in toenail clippings/scrapings as an alternative to hair. Bioanalysis, 6(23):3183-3196.

Hulka, Lea M; Treyer, V; Scheidegger, M; Preller, Katrin H; Vonmoos, M; Baumgartner, M R; Johayem, A; Ametamey, S M; Buck, A; Seifritz, E; Quednow, B B (2014). Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans. Molecular Psychiatry, 19(5):625-632.

Easton, A C; Lourdusamy, A; Havranek, M; Mizuno, K; Solati, J; Golub, Y; Clarke, T-K; Vallada, H; Laranjeira, R; Desrivières, S; Moll, G H; Mössner, R; Kornhuber, J; Schumann, G; Giese, K P; Fernandes, C; Quednow, B B; Müller, C P (2014). αCaMKII controls the establishment of cocaine's reinforcing effects in mice and humans. Translational Psychiatry, 4(e457):online.

Hulka, L M; Preller, K H; Vonmoos, M; Broicher, S D; Quednow, B B (2013). Cocaine users manifest impaired prosodic and cross-modal emotion processing. Frontiers in Psychiatry:4:98.

Petrovsky, N; Ettinger, U; Kessler, H; Mössner, R; Wolfsgruber, S; Dahmen, N; Maier, W; Wagner, M; Quednow, B B (2013). The effect of nicotine on sensorimotor gating is modulated by a CHRNA3 polymorphism. Psychopharmacology, 229(1):31-40.

Bosch, O G; Wagner, M; Jessen, F; Kühn, K U; Joe, A; Seifritz, E; Maier, W; Biersack, H J; Quednow, B B (2013). Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users. PLoS ONE, 8(4):e61234.

Pfaff, M; Seidl, A; Angst, K; Ramseier, F; Seifritz, E; Quednow, B B; Böker, H (2013). Elektrokonvulsionstherapie als Ultima Ratio in der Behandlung der Depression? Behandlungsleitlinien und Zuweisungspraxis. Psychiatrische Praxis, 40(7):385-390.

Petrowsky, N; Ettinger, U; Quednow, B B; Landsberg, M W; Drees, J; Lennertz, L; Frommann, I; Heilmann, K; Sträter, B; Kessler, H; Dahmen, N; Mössner, R; Maier, W; Wagner, M (2013). Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls. International Journal of Neuropsychopharmacology, 16(07):1473-1481.

Hulka, Lea M; Wagner, Michael; Preller, Katrin H; Jenni, Daniela; Quednow, B B (2013). Blue-yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users. International Journal of Neuropsychopharmacology, 16(03):535-547.

Preller, Katrin H; Ingold, Nina; Hulka, Lea M; Vonmoos, Matthias; Jenni, Daniela; Baumgartner, M R; Vollenweider, F X; Quednow, B B (2013). Increased sensorimotor gating in recreational and dependent cocaine users is modulated by craving and attention-deficit/hyperactivity disorder symptoms. Biological Psychiatry, 73(3):225-234.

Quednow, B B (2013). Kokain und das Ego: Soziale Kognition bei Kokainkonsumenten. SuchtMagazin, 3:28-32.

Quednow, B B (2013). Soziale Kognition und Interaktion bei Kokainkonsumenten: Substandinduzierte Beeinträchtigungen können Therapie erschweren. INFO Neurologie & Psychiatrie, 11(5):15-18.

Preller, Katrin H; Wagner, M; Sulzbach, C; Hoenig, K; Neubauer, J; Franke, P E; Petrovsky, N; Frommann, I; Rehme, A K; Quednow, B B (2013). Sustained incentive value of heroin-related cues in short- and long-term abstinent heroin users. European Neuropsychopharmacology, 23(10):1270-1279.

Völter, C; Riedel, M; Aichert, D S; Lobo, S; Costa, A; Schmechtig, A; Collier, D A; Hartmann, A M; Giegling, I; Möller, H J; Quednow, B B; Rujescu, D; Kumari, V; Ettinger, U (2012). Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach. International Journal of Neuropsychopharmacology, 15(10):1427-1440.

Schumacher, Anna; Becker, Tim; Rujescu, D; Quednow, B B; Lennertz, L; Wagner, M; Benninghoff, J; Rietschel, M; Häfner, H; Franke, P; Wölwer, W; Gaebel, W; Maier, W; Mössner, R (2012). Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics. Journal of Psychiatric Research, 46(8):1073-1080.

Quednow, B B (2012). Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating. Proceedings of the National Academy of Sciences of the United States of America, 109(16):6271-6276.

Quednow, B B; Treyer, V; Hasler, F; Dörig, N; Wyss, M T; Burger, C; Rentsch, K M; Westera, G; Schubiger, P A; Buck, A; Vollenweider, F X (2012). Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [(18)F]altanserin positron emission tomography. NeuroImage, 59(4):3922-3932.

Quednow, B B; Pintsov, O (2012). Endophänotypen in der psychiatrischen Forschung - Brückenschlag zwischen Genetk und Psychopathologie? In: Böker, H; Seifritz, E. Psychotherapie und Neurowissenschaften : Integration, Kritik, Zukunftsaussichten. Bern: Hans Huber, 216-233.

Petrovsky, N; Ettinger, U; Quednow, B B; Walter, H; Schnell, K; Kessler, H; Mössner, R; Maier, W; Wagner, M (2012). Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy. Psychopharmacology, 221(1):27-38.

Quednow, B B; Kometer, M; Geyer, M A; Vollenweider, F X (2012). Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology, 37(3):630-640.

Bosch, O G; Quednow, B B; Seifritz, E; Wetter, T C (2012). Reconsidering GHB: orphan drug or new model antidepressant? Journal of Psychopharmacology, 26(5):618-628.

Lennertz, L; Quednow, B B; Schuhmacher, D; Petrovsky, N; Frommann, I; Schulze-Rauschenbach, S; Landsberg, M W; Steinbrecher, A; Höfels, S; Pukrop, R; Klosterkötter, J; Franke, P E; Wölwer, W; Gaebel, W; Häfner, H; Maier, W; Wagner, M; Mössner, R (2012). The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response. International Journal of Neuropsychopharmacology, 15(09):1205-1215.

Mössner, R; Schumacher, A; Wagner, M; Lennertz, L; Steinbrecher, A; Quednow, B B; Rujescu, D; Rietschel, M; Maier, W (2012). The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms. European Archives of Psychiatry and Clinical Neuroscience, 262(3):193-197.

Lennertz, L; Quednow, B B; Benninghoff, J; Wagner, M; Maier, W; Mössner, R (2011). Impact of TCF4 on the genetics of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 261(Suppl 2):161-165.

Quednow, B B (2011). Muss nur die Chemie stimmen? Verbesserung der Gehirnleistung durch Drogen und Neuropsychopharmaka. In: Vogelsang, F; Hoppe, C. Sollen wir den Menschen verbessern? Versprechungen und Perspektiven des Neuroenhancements. Bonn: Evangelische Akademie im Rheinland , 57-73.

Quednow, B B; Ettinger, U; Mössner, R; Rujescu, D; Giegling, I; Collier, D A; Schmechtig, A; Kühn, K U; Möller, H J; Maier, W; Wagner, M; Kumari, V (2011). The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. Journal of Neuroscience, 31(18):6684-6691.

Mössner, R; Schumacher, A; Wagner, M; Quednow, B B; Frommann, I; Kühn, K U; Schwab, S G; Rietschel, M; Falkai, P; Wölwer, W; Ruhrmann, S; Bechdolf, A; Gaebel, W; Klosterkötter, J; Maier, W (2010). DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis. European Archives of Psychiatry and Clinical Neuroscience, 260(3):209-215.

Quednow, B B (2010). Ethics of neuroenhancement: a phantom debate. [Book review of: Bettina Schöne-Seifert, Davinia Talbot, Uwe Opolka and Johann S Ach (eds.), Neuro-Enhancement. Ethik vor neuen Herausforderungen, Paderborn: mentis, 2009]. BioSocieties, 5(1):153-156.

Quednow, B B; Wagner, M; Mössner, R; Maier, W; Kühn, K U (2010). Sensorimotor gating of schizophrenia patients depends on catechol O-methyltransferase Val158Met polymorphism. Schizophrenia Bulletin, 36(2):341-346.

Quednow, B B (2010). Neurophysiologie des Neuro-Enhancements: Möglichkeiten und Grenzen. SuchtMagazin, 36(2):19-26.

Petrovsky, N; Quednow, B B; Ettinger, U; Schmechtig, A; Mössner, R; Collier, D A; Kühn, K U; Maier, W; Wagner, M; Kumari, V (2010). Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology, 35(7):1429-1439.

Quednow, B B (2010). Tyrannische Neurobiologie und unterdrückte Kultur des psychotropen Erlebens. Zeitschrift für Kulturwissenschaften, (2):79-84.

Quednow, B B; Geyer, M A; Halberstadt, A L (2009). Serotonin and Schizophrenia. In: Müller, C R; Jacobs, B. Handbook of the Behavioral Neurobiology of Serotonin. London: Academic Press, 585-620.

Rehme, A K; Frommann, I; Peters, S; Block, V; Bludau, J; Quednow, B B; Maier, W; Schütz, C; Wagner, M (2009). Startle cue-reactivity differentiates between light and heavy smokers. Addiction, 104(10):1757-1764.

Schumacher, A; Mössner, R; Quednow, B B; Kühn, K U; Wagner, M; Cvetanovska, G; Rujescu, D; Zill, P; Möller, H J; Rietschel, M; Franke, P; Wölwer, W; Gaebel, W; Maier, W (2009). Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia. Pharmacogenetics and Genomics, 19(11):843-851.

Quednow, B B; Schmechtig, A; Ettinger, U; Petrovsky, N; Collier, D A; Vollenweider, F X; Wagner, M; Kumari, V (2009). Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study. Biological Psychiatry, 66(6):614-620.

Hasler, F; Kuznetsova, O F; Krasikova, R N; Cservenyak, T; Quednow, B B; Vollenweider, F X; Ametamey, S M; Westera, G (2009). GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies. Applied Radiation and Isotopes, 67(4):598-601.

Quednow, B B. Pharmakologische und psychopathologische Modulation des sensomotorischen Gatings. 2009, University of Zurich, Faculty of Arts.

Mössner, R; Schumacher, A; Kühn, K U; Cvetanovska, G; Rujescu, D; Zill, P; Quednow, B B; Rietschel, M; Wölwer, W; Gaebel, W; Wagner, M; Maier, W (2009). Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia. Pharmacogenetics and Genomics, 19(1):91-94.

Quednow, B B; Frommann, I; Berning, J; Kühn, K U; Maier, W; Wagner, M (2008). Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biological Psychiatry, 64(9):766-773.

Maier, W; Mössner, R; Quednow, B B; Wagner, M; Hurlemann, R (2008). From genes to psychoses and back: the role of the 5HT2alpha-receptor and prepulse inhibition in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 258(Supp. 5):40-43.

Westheide, J; Quednow, B B; Kühn, K U; Hoppe, C; Cooper-Mahkorn, D; Hawellek, B; Eichler, P; Maier, W; Wagner, M (2008). Executive performance of depressed suicide attempters: the role of suicidal ideation. European Archives of Psychiatry and Clinical Neuroscience, 258(7):414-421.

Quednow, B B; Kühn, K U; Mössner, R; Schwab, S G; Schuhmacher, A; Maier, W; Wagner, M (2008). Sensorimotor gating of schizophrenia patients is influenced by 5-HT2A receptor polymorphisms. Biological Psychiatry, 64(5):434-437.

Quednow, B B (2008). Defizite der sensomotorischen Filterleistung bei psychiatrischen Erkrankungen. Zeitschrift für Neuropsychologie, 19(3):139-163.

Csomor, P A; Yee, B K; Vollenweider, F X; Feldon, J; Nicolet, T; Quednow, B B (2008). On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behavioral Neuroscience, 122(4):885-900.

Quednow, B B; Csomor, P A; Chmiel, J; Beck, T; Vollenweider, F X (2008). Sensorimotor gating and attentional set-shifting are improved by the μ-opioid receptor agonist morphine in healthy human volunteers. International Journal of Neuropsychopharmacology, 11:655-669.

Pfaff, M; Quednow, B B; Brüne, M; Juckel, G (2008). Schizophrenia and religiousness--a comparative study at the time of the two German states. Psychiatrische Praxis, 35(5):240-246.

This list was generated on Wed Sep 20 12:14:14 2017 CEST.